Table 2.

Incidence and severity of AOD in d3tx B6AF1 mice that received different numbers of Tregs from donors with or without ovaries





AOD in d3tx recipients
Treg donor
Treg donor treatment
Treg nos.
Incidence,% (no.)
Severity*
None   –   –   92 (25)   8.0 ± 0.8  
Female 1   –   3 × 104  100 (9)   4.0 ± 1.3  
Female 2   –   1 × 105  44 (9)   3.7 ± 1.8  
Female 3   –   3 × 105  23 (13)   2.3 ± 0.6  
Female 4   –   5 × 105  0 (32)   –  
Male 1   –   3 × 104  81 (16)   5.6 ± 1.0  
Male 2   –   1 × 105  45 (11)   5.4 ± 1.7  
Male 3   –   3 × 105  23 (13)   1.5 ± 0.3  
Male 4   –   5 × 105  0 (15)   –  
Female 5   NOv   3 × 105  55 (11)   1.0 ± 0.1  
Female 6
 
NOv
 
5 × 105
 
0 (8)
 

 




AOD in d3tx recipients
Treg donor
Treg donor treatment
Treg nos.
Incidence,% (no.)
Severity*
None   –   –   92 (25)   8.0 ± 0.8  
Female 1   –   3 × 104  100 (9)   4.0 ± 1.3  
Female 2   –   1 × 105  44 (9)   3.7 ± 1.8  
Female 3   –   3 × 105  23 (13)   2.3 ± 0.6  
Female 4   –   5 × 105  0 (32)   –  
Male 1   –   3 × 104  81 (16)   5.6 ± 1.0  
Male 2   –   1 × 105  45 (11)   5.4 ± 1.7  
Male 3   –   3 × 105  23 (13)   1.5 ± 0.3  
Male 4   –   5 × 105  0 (15)   –  
Female 5   NOv   3 × 105  55 (11)   1.0 ± 0.1  
Female 6
 
NOv
 
5 × 105
 
0 (8)
 

 

NOv indicates neonatal ovariectomy; –, none.

*

Mean ± SD of mice with disease

or Create an Account

Close Modal
Close Modal